Bringing LSPR Nanotechnology to In Vitro Diagnostics and Life Sciences
LamdaGen has developed a digital LSPR nanotechnology detection platform that enables diagnostic sensitivities and precise quantitation at levels far beyond the expected. Our patented nano-structured Localized Surface Plasmon Resonance technology (LSPR nanotechnology) produces highly robust biosensors in the form of metallic thin films that exhibit remarkable diagnostic detection capabilities into the mid-femtomolar range.
The Company’s digital diagnostic technology enables decentralized acute care testing at the point of need and is compatible with any biomarker, including newly identified low-abundance ones for stroke, heart attack, cancer, neurodegenerative and infectious disease.
Saliva-based Cortisol Assay: Read More ›
Troponin I (cTnI) Ap Note: Read More ›
Platform for Next Generation Diagnostics: Read More ›